Results 191 to 200 of about 519,424 (339)

Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma. [PDF]

Int J Mol Sci
Yannakou CK, Wu S, Rajah K, Abeyakoon C, Nguyen-Ngo C, Yap YZ, Sheldon J, Blombery P, Prince HM.   +8 more
europepmc   +1 more source

Chromosome translocations involving band 7q35 or 7p15 in childhood T- cell leukemia/lymphoma [PDF]

, 1988
Y Kaneko, Nobuo Maseki, Chieko Homma, M Sakurai, Shuki Mizutani, Takeo Takeda, T Shikano, T Fujimoto, K Yaoi, T Shimokawa   +9 more
openalex   +1 more source

Combining PIM‐2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding

Advanced Science, EarlyView.
The findings suggest that the combination of PIM‐2 and PARP1 inhibitors can induce MICA expression on MM cells, thereby activating NK cells through NKG2D binding. This process may restore NK cell function and serve as a potential therapeutic approach for MM patients. Abstract While immunogenic death in tumor cells activates specific anti‐tumor T cells,
Zhaoyun Liu, Wenhui Lei, Xiaohan Liu, Hui Liu, Kai Ding, Jia Song, Rong Fu   +6 more
wiley   +1 more source

Hepatosplenic T-cell lymphoma in children and adolescents. [PDF]

Blood Adv
Schwartz LF, Devine KJ, Xavier AC.
europepmc   +1 more source

Adult T cell lymphoma with hypergammaglobulinemia

, 1980
Shaw Watanabe, Yukío Shimosato, M Shimoyama, K Minato, Minoru Suzuki, Mitsunobu Abe, Tetsuo Nagatani   +6 more
openalex   +1 more source

A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T- cell lymphoma mimicking malignant histiocytosis [PDF]

, 1989
Yasuhiko Kaneko, Glauco Frizzera, S Edamura, Nobuo Maseki, M Sakurai, Yoshihiro Komada, M Sakurai, H Tanaka, M. Sasaki, Taizan Suchi   +9 more
openalex   +1 more source

Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions

Advanced Science, EarlyView.
Brain metastases (BM) from lung cancer are aggressive with poor prognosis. This review covers clinical features, diagnosis, early metastasis, and multi‐omics‐elucidated mechanisms, especially the tumor microenvironment of lung cancer with BM. It also discusses preclinical models, signaling pathways, and emerging therapies.
Yixiang Zhu, Danming He, Zan Hou, Mei Lan, Ye Zhang, Qifeng Wang   +5 more
wiley   +1 more source

Erythrodermic cutaneous T-cell lymphoma: Insights from a Kenyan perspective. [PDF]

JAAD Int
Mutio C, Wanyika H, Zuriel D, Ndarathi C.   +3 more
europepmc   +1 more source

Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer

Advanced Science, EarlyView.
Breast cancer cells undergo metabolic and transcriptomic reprogramming to support aberrant cell proliferation. Their mitochondria rely on the transfer of phosphatidylcholine from the endoplasmic reticulum to their membranes by STARD7, a candidate upregulated in breast cancer, to be functional.
Ewelina Dondajewska, Paula Allepuz‐Fuster, Chloé Maurizy, Alexandre Hego, Sandra Ormenese, Quentin Lion, Arnaud Blomme, Pierre Close, Arnaud Lavergne, Latifa Karim, Marc Thiry, Ivan Nemazanyy, Roopesh Krishnankutty, Jair Marques Jr, Alex von Kriegsheim, Nathaniel F. Henneman, Ganna Panasyuk, Kateryna Shostak, Alain Chariot   +18 more
wiley   +1 more source

A Finnish nationwide population-based study on the survival of patients with peripheral T-cell lymphoma. [PDF]

Sci Rep
Reunamo T, Kalashnikov I, Lahtela K, Pollari M, Viisanen L, Mannisto S, Jyrkkiö S, Leppä S.   +7 more
europepmc   +1 more source